My Account
Nov 20, 2020 01:47 PM IST The most noted point after September quarter earnings season was that more than 100 stocks witnessed upgrade in rating to buy from brokerages.
Jan 13, 2020 08:32 AM IST This Friday, Nifty continued its northward trajectory and with the help of complete gush, managed to clock fresh record highs beyond 12,300.
Dec 30, 2019 08:08 AM IST "We had a good broad-based rally in the market where few marquee large-cap names joined hands with quality mid-cap counters. It’s a sign of a healthy bull run, which we believe is likely to continue."
Nov 04, 2019 10:01 AM IST The BSE Sensex already surpassed earlier record-high and made a fresh high of 40,392.22 last week, showing over 11 percent gains from September lows.
Oct 19, 2019 02:05 PM IST The S&P BSE Mid-cap index gained 4.64 percent, S&P BSE Large-cap index rose 3.49 percent and the Small-cap Index was up 2.78 percent last week.
Nov 26, 2018 08:02 AM IST Rajesh Agarwal of AUM Capital recommends buying RBL Bank with stop loss at Rs 552 and target of Rs 567, Indoco Remedies with stop loss at Rs 194 and target of Rs 210 and Adani Gas with stop loss at Rs 105 and target of Rs 120.
Nov 23, 2017 08:47 AM IST Ashwani Gujral of ashwanigujral.com has a buy on Rain Industries with a stop loss of Rs 315, target of Rs 332, a buy on United Breweries with a stop loss of Rs 1090, target of Rs 1150 and a buy on Sun Pharma Advanced Research with a stop loss of Rs 410, target of Rs 435.
Oct 11, 2017 07:58 AM IST Jay Thakkar of Anand Rathi Securities advises buying Greaves Cotton with a target of Rs 142.75.
Oct 09, 2017 07:59 AM IST Jay Thakkar of Anand Rathi Securities is of the view that one may sell RBL Bank Future with a target of Rs 506.
Aug 24, 2017 09:40 AM IST Moneycontrol analysed pharma stocks with a market cap of over Rs 1,000 crore. In order to find out if there are any scrips available at a reasonable valuation, we used five-year average price-to-earnings as a filter
Apr 05, 2017 02:39 PM IST Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today - Neuland Labs, Titan, Cyient, Indoco Remedies, Shankara Buildpro, Ashok Leyland, TVS Motor, Tata Motors, and AB Money.
Sep 27, 2016 04:40 PM IST Expressing concern that drug majors are running out of cash in the US market and their generics business is shrinking, Surajit Pal of Prabhudas Lilladher said he doesn‘t expect great returns from large-cap pharma stocks.
Jul 18, 2016 03:08 PM IST According to Ashwani Gujral of ashwanigujral.com, one can sell Indoco Remedies and Canara Bank and buy CESC.
Mar 14, 2016 01:24 PM IST Mahantesh Sabarad of SBI Capital Securities has a positive view on midcap pharma including Indoco Remedies.
Mar 04, 2016 11:49 AM IST Ashwani Gujral of ashwanigujral.com recommends selling Dish TV and Indoco Remedies and advises buying JBF Industries.
Oct 15, 2015 07:55 AM IST Shahina Mukadam, Independent Market Expert advises buying Zee Media Corporation with a target of Rs 24.
Aug 18, 2015 04:46 PM IST Sudip Bandopadhyay of Destimoney Securities is of the view that Glenmark Pharma is the top pick and likes Ipca Labs and Indoco Remedies.
Jul 17, 2015 04:32 PM IST Sudip Bandopadhyay of Destimoney Securities is of the view that one may prefer midcap stocks like Mangalam Cement, Mahindra CIE and Ramkrishna Forgings.
Jan 02, 2015 04:05 PM IST Daljeet S Kohli, Head of Research at Indianivesh Securities feels that Indoco Remedies may touch Rs 392.
Sep 09, 2014 02:36 PM IST Manas Jaiswal of manasjaiswal.com is of the view that one can hold Indoco Remedies as the stock has potential to test Rs 335 in next three to four trading sessions.
Feb 12, 2014 01:18 PM IST Sandeep Shenoy of Anand Rathi Financial Services is of the view that one may prefer Ipca Laboratories, Unichem Laboratories and Indoco Remedies from the pharma space.
Dec 20, 2013 01:04 PM IST Sriram Rathi, pharma analyst at Anand Rathi is of the view that one may pick Cipla and Dr Reddys Laboratories from largecap pharma space.
Nov 29, 2013 09:05 AM IST Nooresh Merani of AMSEC Research advises buying Tata Global Beverage for a target price of Rs 155 and Godrej Industries for a target price of Rs 290.
Jun 16, 2011 02:05 PM IST Gaurav Jain of Hem Securities has recommended investing in Indoco Remedies.
Apr 08, 2011 11:31 AM IST Indoco Remedies can test Rs 600, says SP Tulsian, sptulsian.com.
